Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3758 results

Sort By:

A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances

Study ID: NCT06685965
Start Date: 2025-08-01
End Date: 2026-08-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Ri 03

Placebo

Sponsor

Reconnect Labs

Source: clinicaltrials.gov

Share:
Add to list

Refining Risk Prediction Models for Older Adults Using Electronic Health Records

Study ID: NCT06995365
Start Date: 2025-08
End Date: 2026-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

18000

Intervention / Treatment

Risk Prediction Model

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list

New Laser and Suction Sheath for Kidney Stone Treatment

Study ID: NCT06667466
Start Date: 2025-11-20
End Date: 2027-11-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

Super Pulsed Thulium Fiber Laser (sTFL) + Flexible Negative Pressure Ureteral Access Sheath (UAS) Intervention

Super Pulsed Thulium Fiber Laser (sTFL) + Conventional Ureteral Access Sheath (UAS) Intervention

Sponsor

Y is good

Source: clinicaltrials.gov

Share:
Add to list

Creative Arts Therapy on Body Image, Self-esteem, Anxiety and Depression in Post-Treatment Prostate Cancer Patients

Study ID: NCT07015866
Start Date: 2025-07-30
End Date: 2027-07-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

Guided therapy group

Creative arts therapy

Sponsor

The Hong Kong Polytechnic University

Source: clinicaltrials.gov

Share:
Add to list

Exercise-induced Cardioversion in Persistent Atrial Fibrillation

Study ID: NCT07008066
Start Date: 2025-09-01
End Date: 2026-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Bicycle ergometer excercise

Standard care with electrical cardioversion

Sponsor

Uppsala University

Source: clinicaltrials.gov

Share:
Add to list

Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients

Study ID: NCT07060274
Start Date: 2025-09
End Date: 2027-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

64

Intervention / Treatment

Doppler Ultrasound

Sponsor

Le Mans hospital center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Study ID: NCT07044765
Start Date: 2025-08
End Date: 2025-11
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Comparator 1

Comparator 2

Test Drug

Sponsor

To Aju firm., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera

Study ID: NCT06290765
Start Date: 2026-02-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

70

Intervention / Treatment

Ropeginterferon alfa-2b

Phlebotomy and aspirin

Sponsor

Pharmesentia

Source: clinicaltrials.gov

Share:
Add to list

Assessment of Interprofessional Competencies of Healthcare Professionals Before and After Healthcare Simulation Sessions

Study ID: NCT07064265
Start Date: 2025-08-15
End Date: 2026-03-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment
Sponsor

Gonesse Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Study ID: NCT06904066
Start Date: 2025-07-21
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

86

Intervention / Treatment

Aldesleukin

cyclophosphamide

fludarabine phosphate

Individual Patient TCR-Transduced PBL

TruSight Oncology (TSO) 500

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list